Inadequate Clinical Response to Sirukumab, an Anti-IL-6 Monoclonal Antibody, Can be Predicted after a Single Dose of Treatment in Patients with Rheumatoid Arthritis

被引：0

作者：

Daga, Shruti ^{[1
]}

Aletaha, Daniel ^{[2
]}

Hsu, Benjamin ^{[3
]}

Gilbride, Jennifer ^{[4
]}

Christie, Jacquie ^{[5
]}

Loza, Matthew ^{[3
]}

Dasgupta, Bidisha ^{[3
]}

Campbell, Kim ^{[3
]}

Brown, Kurt ^{[6
]}

Rao, Ravi ^{[5
]}

Tak, Paul P. ^{[5
]}

机构：

[1] GlaxoSmithKline, Uxbridge, Middx, England

[2] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria

[3] Janssen Res & Dev LLC, Spring House, PA USA

[4] Sum Sq Ltd, Walkern, Herts, England

[5] GlaxoSmithKline, Stevenage, Herts, England

[6] GlaxoSmithKline, Collegeville, PA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1478

引用

页数：3

共 50 条

[31] Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis
Pulito-Cueto, V
Remuzgo-Martinez, S.
Genre, F.
Calvo-Alen, J.
Aurrecoechea, E.
Llorente, I
Triguero-Martinez, A.
Blanco, R.
Llorcas, J.
Ruiz-Lucea, E.
Rivera-Garcia, N.
Gualillo, O.
Lopez-Mejias, R.
Castaneda, S.
Gonzalez-Gay, M. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (06) : 1201 - 1205
[32] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis
Miyagawa, Ippei
Nakayamada, Shingo
Saito, Kazuyoshi
Hanami, Kentaro
Nawata, Masao
Sawamukai, Norifumi
Nakano, Kazuhisa
Yamaoka, Kunihiro
Tanaka, Yoshiya
MODERN RHEUMATOLOGY, 2014, 24 (03) : 405 - 409
[33] RESULTS FROM A MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF SIRUKUMAB, A HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
Hsu, B.
Sheng, S.
Weinblatt, M. E.
Smolen, J. S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 61 - 61
[34] WORK PRODUCTIVITY AND GENERAL HEALTH STATUS IMPROVEMENTS WITH SIRUKUMAB, AN ANTI-IL-6 CYTOKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE ANTI-TNF THERAPY: RESULTS FROM THE PHASE 3 SIRROUND-T STUDY
Tanaka, Y.
Aletaha, D.
Peterson, S.
Ganguly, R.
Kurrasch, R.
Popik, S.
Agarwal, P.
Li, N.
VALUE IN HEALTH, 2017, 20 (05) : A149 - A149
[35] Molecular mechanism of Anti-IL-6 receptor antibody treatment in collagen-induced arthritis
Fuiimoto, Minoru
Serada, Satoshi
Matsukawa, Yuko
Nakano, Mayumi
Nishikawa, Teppei
Kishimoto, Tadamitsu
Naka, Tetsuji
CYTOKINE, 2007, 39 (01) : 11 - 11
[36] SIRUKUMAB, AN ANTI-IL-6 CYTOKINE MONOCLONAL ANTIBODY, LEADS TO IMPROVEMENTS IN WORK PRODUCTIVITY AND GENERAL HEALTH STATUS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS FROM THE PHASE 3 SIRROUND-T STUDY
Tanaka, Y.
Aletaha, D.
Peterson, S.
Ganguly, R.
Kurrasch, R.
Popik, S.
Agarwal, P.
Li, N.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 580 - 580
[37] Efficacy of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, Based upon Prior Use of Non-Anti-TNF Biologics in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Global Phase 3 Study
Tanaka, Yoshiya
Aletaha, Daniel
Bingham, Clifton, III
Agarwal, Prasheen
Kurrasch, Regina
Popik, Sharon
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[38] Exposure-Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid Arthritis
Xu, Yan
Hu, Chuanpu
Zhuang, Yanli
Hsu, Benjamin
Xu, Zhenhua
Sharma, Amarnath
Zhou, Honghui
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (11): : 1501 - 1515
[39] Results From a Multicenter, International, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Sirukumab, a Human Anti-IL-6 Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
Hsu, Benjamin
Sheng, Shihong
Weinblatt, Michael E.
Smolen, Josef
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1035 - S1035
[40] Efficacy and Safety of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study
Aletaha, Daniel
Bingham, Clifton, III
Tanaka, Yoshiya
Agarwal, Prasheen
Kurrasch, Regina
Tak, Paul-Peter
Popik, Sharon
ARTHRITIS & RHEUMATOLOGY, 2016, 68

← 1 2 3 4 5 →